Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution

E-ISSN： 1875-5666|12|9|1108-1124

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.12, Iss.9, 2012-11, pp. : 1108-1124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hsp90 inhibitors as novel cancer chemotherapeutic agents

By Neckers L.

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

17 AAG for HSP90 Inhibition in Cancer - From Bench to Bedside

Current Molecular Medicine, Vol. 9, Iss. 5, 2009-06 ,pp. : 654-664

Bentham Science Publishers

Access to resources Recommend Favorite

Elevated Levels of the 90 kDa Heat Shock Protein (hsp90) in SLE Correlate with Levels of IL-6 and Autoantibodies to hsp90

By Ripley B.J.M. Isenberg D.A. Latchman D.S.

Journal of Autoimmunity, Vol. 17, Iss. 4, 2001-12 ,pp. : 341-346

Academic Press

Access to resources Recommend Favorite

Function of HSP90 and p23 in the Telomerase Complex of Thyroid Tumors

By Boltze Carsten Schneider-Stock Regine Roessner Albert Quednow Claudia Hoang-Vu Cuong

Pathology Research and Practice, Vol. 199, Iss. 9, 2003-10 ,pp. : 573-579

Urban & Fischer

Access to resources Recommend Favorite

Human Recombinant Antibody to HSP90: A Natural Partner in Combination Therapy

Current Molecular Medicine, Vol. 5, Iss. 4, 2005-06 ,pp. : 403-411

Bentham Science Publishers

Access to resources Recommend Favorite